Literature DB >> 10922253

Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy.

N T Nguyen1, D M Follette, B M Wolfe, P D Schneider, P Roberts, J E Goodnight.   

Abstract

HYPOTHESIS: Minimally invasive esophagectomy can be performed as safely as conventional esophagectomy and has distinct perioperative outcome advantages.
DESIGN: A retrospective comparison of 3 methods of esophagectomy: minimally invasive, transthoracic, and blunt transhiatal.
SETTING: University medical center. PATIENTS: Eighteen consecutive patients underwent combined thoracoscopic and laparoscopic esophagectomy from October 9, 1998, through January 19, 2000. These patients were compared with 16 patients who underwent transthoracic esophagectomy and 20 patients who underwent blunt transhiatal esophagectomy from June 1, 1993, through August 5, 1998. MAIN OUTCOME MEASURES: Operative time, amount of blood loss, number of operative transfusions, length of intensive care and hospital stays, complications, and mortality.
RESULTS: Patients who had minimally invasive esophagectomy had shorter operative times, less blood loss, fewer transfusions, and shortened intensive care unit and hospital courses than patients who underwent transthoracic or blunt transhiatal esophagectomy. There was no significant difference in the incidence of anastomotic leak or respiratory complications among the 3 groups.
CONCLUSION: Minimally invasive esophagectomy is safe and provides clinical advantages compared with transthoracic and blunt transhiatal esophagectomy.

Entities:  

Mesh:

Year:  2000        PMID: 10922253     DOI: 10.1001/archsurg.135.8.920

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  77 in total

1.  A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma.

Authors:  Hiroyuki Daiko; Mitsuyo Nishimura
Journal:  Surg Endosc       Date:  2011-09-23       Impact factor: 4.584

2.  Minimally invasive surgical approaches to esophageal cancer.

Authors:  Lee L Swanstrom
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

3.  Totally laparoscopic transhiatal esophago-gastrectomy without thoracic or cervical access. The least invasive surgery for adenocarcinoma of the cardia?

Authors:  R Costi; J Himpens; J Bruyns; G B Cadière
Journal:  Surg Endosc       Date:  2004-03-19       Impact factor: 4.584

Review 4.  Thoracoscopic esophagectomy in the prone position.

Authors:  Omar A Jarral; Sanjay Purkayastha; Thanos Athanasiou; Ara Darzi; George B Hanna; Emmanouil Zacharakis
Journal:  Surg Endosc       Date:  2012-03-07       Impact factor: 4.584

5.  Mediastinoscopy-assisted esophagectomy for esophageal cancer in patients with serious comorbidities.

Authors:  Naohiko Koide; Daisuke Takeuchi; Akira Suzuki; Shinichi Miyagawa
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

6.  Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.

Authors:  Panteleimon Kountourakis; Jaffer A Ajani; Marta Davila; Jeffrey H Lee; Manoop S Bhutani; Julie G Izzo
Journal:  Gastrointest Cancer Res       Date:  2012-03

Review 7.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

8.  Esophagectomy for Barrett's esophagus: indications, techniques, and outcome.

Authors:  Ninh T Nguyen; Ken Chang; Tarlan Nahidi; Samuel E Wilson; James D Luketich
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

9.  Esophagectomy without mortality: what can surgeons do?

Authors:  Simon Law
Journal:  J Gastrointest Surg       Date:  2009-09-23       Impact factor: 3.452

10.  Comparative experience of open and minimally invasive esophagogastric resection.

Authors:  Rajeev Parameswaran; Darmarajah Veeramootoo; Rakesh Krishnadas; Martin Cooper; Richard Berrisford; Shahjehan Wajed
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.